Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes.

Reinhard, H; Jacobsen, P Karl; Lajer, M; Pedersen, N; Billestrup, N; Mandrup-Poulsen, T; Parving, H-H; Rossing, P

Reinhard, H; Jacobsen, P Karl; Lajer, M; Pedersen, N; Billestrup, N; Mandrup-Poulsen, T; Parving, H-H; Rossing, P.

Affiliation

Reinhard H; Steno Diabetes Center, Niels Steensenvej 1, DK-2820 Gentofte, Denmark. hnri@steno.dk

Diabetologia ; 53(10): 2129-33, 2010 Oct.

Article in En | MEDLINE | ID: mdl-20607514

Subject(s)

Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/therapy; Endothelial Cells/cytology; Stem Cells/cytology; Angiotensin Receptor Antagonists/therapeutic use; Aspirin/therapeutic use; Cell Count; Cells, Cultured; Diet, Reducing; Exercise Therapy; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Leukocytes, Mononuclear/cytology; Life Style; Male; Metformin/therapeutic use; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Stem Cells / Endothelial Cells / Diabetes Mellitus, Type 2 Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Year: 2010 Type: Article

Fulltext

XML

PubMed Links

Search on Google